Delivery Order SPE2DB22D1202-SPE2DB24FURG6
Award Date 2/22/24
Potential Completion Date 2/23/24
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $45,168.10 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XELJANZ XR 11 MG TABLET UU 30S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XELJANZ XR 11 MG TABLET UU 30S. This $1,879.09 contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. The company holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $5,239.68 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XELJANZ XR 11 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of XELJANZ 10 MG Tablet UU 60S. The $10,161.32 contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA for pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product XELJANZ XR 11 MG TABLET. The award has a potential value of $3,207.44 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XELJANZ XR 11 mg tablets. The potential value of this delivery order is $3,014.72 and the period of performance extends through February 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,916.28 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XELJANZ XR 11 MG TABLET UU 30S. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,522.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XELJANZ XR 11 MG TABLET UU 30S. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025 that enables Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply XELJANZ XR 11 MG TABLET UU 30S. The $18,313.65 contract has a completion date of March 25, 2022 and was awarded on March 24, 2022. Amerisourcebergen Drug Corp, as the prime contractor, provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $4,263.36 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XELJANZ 5 MG TABLET UU 60S. This delivery order contract has a completion date of February 7, 2024 and was awarded on February 6, 2024. Amerisourcebergen Drug Corp also holds a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical,...